Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „cause“
Suchtreffer
Begriffe & Kennungen
Aerinaze · 4.5 · Sympathomimetics Reversible and irreversible MAO inhibitor(s) may cause: risk of vasoconstriction and increase
Eintrag öffnenAmbirix · 4.8 · 6 Because these events were reported spontaneously, it is not possible to reliably estimate their frequency.
Eintrag öffnenAptivus · 4.5 · Concomitant use of Aptivus/ritonavir caused a decrease of etravirine exposure that could significantly impair
Eintrag öffnenArava · 4.3 · • Patients with moderate to severe renal insufficiency, because insufficient clinical experience is available
Eintrag öffnenArava · 4.3 · • Patients with moderate to severe renal insufficiency, because insufficient clinical experience is available
Eintrag öffnenArava · 4.3 · • Patients with moderate to severe renal insufficiency, because insufficient clinical experience is available
Eintrag öffnenAripiprazole Sandoz · 4.5 · If aripiprazole is administered concomitantly with medicinal products known to cause QT prolongation or electr
Eintrag öffnenAubagio · 4.3 · Patients with severe renal impairment undergoing dialysis, because insufficient clinical experience is availab
Eintrag öffnenAzarga · 4.8 · Timolol is absorbed into the systemic circulation. This may cause similar adverse reactions as seen with syste
Eintrag öffnenBalversa · 4.8 · Hyperphosphataemia and soft tissue mineralisation Erdafitinib can cause hyperphosphataemia. Increases in phosp
Eintrag öffnenBalversa · 4.8 · Hypophosphataemia Erdafitinib can cause hypophosphataemia. Hypophosphataemia occurred in 5.6% of patients. Hyp
Eintrag öffnenBeromun · 4.5 · Combinations with cardiotoxic substances (e.g. anthracyclines) should be avoided because it is possible that t
Eintrag öffnenBeromun · 4.5 · Concurrent administration of agents likely to cause significant hypotension is not recommended (see section 4.
Eintrag öffnenBeyonttra · 4.5 · Based on in vitro studies, acoramidis is unlikely to cause any clinically relevant uridine 5'-diphospho (UDP)-
Eintrag öffnenBlincyto · 4.5 · Initiation of BLINCYTO treatment causes transient release of cytokines during the first days of treatment that
Eintrag öffnenBonviva · 4.5 · In healthy male volunteers and postmenopausal women, intravenous administration of ranitidine caused an increa
Eintrag öffnenBuccolam · 4.5 · Co-administration with midazolam may cause enhanced sedation or respiratory and cardiovascular depression.
Eintrag öffnenBuccolam · 4.5 · Co-administration with midazolam may cause enhanced sedation or respiratory or cardiovascular depression. Mida
Eintrag öffnenBuccolam · 4.5 · Co-administration with protease inhibitors (e.g. Saquinavir and other HIV protease inhibitors) may cause a lar
Eintrag öffnenBuccolam · 4.5 · E.g. baclofen. Midazolam may cause potentiation of muscle relaxants, with increased CNS depressant effects.
Eintrag öffnen